Background
Description | Gene symbol |
---|---|
thyroid transcription factor-1 | TTF-1 |
GALECTIN 3
|
GAL3
|
Calcitonin | CALCA |
HEMATOPOIETIC PROGENITOR CELL ANTIGEN CD34 | CD34 |
keratin, type I cytoskeletal 19
|
CK19
|
Thyroglobulin
|
Tg
|
KI67 Antigen
|
MKI67
|
TUMOR PROTEIN p53 | P53 |
Materials and methods
Reagents
Immunohistochemistry
Immunohistochemical Evaluation
Statistical Analysis
Results
Immunohistochemistry results
Nonmalignant lesions N = 151 | PTC N = 441 | X2 | P | ||
---|---|---|---|---|---|
CK19
|
+
| 39(25.83) | 425(96.37) | 326.17 | 6.56E-73 |
- | 112(74.17) | 16(3.63) | |||
Tg
|
+
| 120(79.47) | 365(82.77) | 0.62 | 0.43 |
- | 31(20.53) | 76(17.23) | |||
Ki67
|
+
| 56(37.09) | 179(40.59) | 0.44 | 0.51 |
- | 95(62.91) | 262(59.41) | |||
Galectin
|
+
| 77(50.99) | 427(96.82) | 183.10 | 1.02 E-41 |
- | 74(49.01) | 14(3.18) |
nodular goiter n = 97 | Follicular adenoma N = 54 | PTC1 N = 248 | PTC2 N = 193 | |||
---|---|---|---|---|---|---|
CK19
|
+
|
Female
| 21(21.65) | 10(18.52) | 202(81.45) | 121(62.69) |
Male
| 5(5.15) | 3(5.56) | 44(17.75) | 58(30.05) | ||
- |
Female
| 52(53.61) | 30(55.56) | 0(0.00) | 8(4.15) | |
Male
| 19(19.59) | 11(20.36) | 2(0.80) | 6(3.11) | ||
Galectin
|
+
|
Female
| 37(38.15) | 19(35.19) | 196(79.03) | 122(63.21) |
Male
| 14(14.43) | 7(12.96) | 45(18.14) | 64(33.16) | ||
- |
Female
| 36(37.11) | 21(38.89) | 6(2.43) | 7(3.63) | |
Male
| 10(10.31) | 7(12.96) | 1(0.40) | 0(0.00) |
SN | SP | FNR | FPR | DAC | |
---|---|---|---|---|---|
CK19
| 96.37% | 74.17% | 3.63% | 25.83% | 90.71% |
Galectin-3
| 96.82% | 49.01% | 3.18% | 50.99% | 84.63% |